Small-cell carcinoma of the urinary bladder: diagnosis and management

References

• Cramer SF, Aikawa M, Cebelin M. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer47, 724–730 (1981).
   PubMed Web of Science ®Google Scholar
• Blomjous CE, Vos W, De Voogt HJ, Van der Valk P, Meijer CJ. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer64, 1347–1357 (1989).
   PubMed Web of Science ®Google Scholar
• Cheng L, Pan CX, Yang XJ et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer101, 957–962 (2004).
   PubMed Web of Science ®Google Scholar
• Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer103, 1172–1178 (2005).
   PubMed Web of Science ®Google Scholar
• Abrahams NA, Moran C, Reyes AO, Siefker-Radtke A, Ayala AG. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases. Histopathology46, 57–63 (2005).
   PubMed Web of Science ®Google Scholar
• Wang HL, Lu DW. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am. J. Surg. Pathol.28, 901–908 (2004).
   PubMed Web of Science ®Google Scholar
• Terracciano L, Richter J, Tornillo L et al. Chromosomal imbalances in small cell carcinomas of the urinary bladder. J. Pathol.189, 230–235 (1999).
   PubMed Web of Science ®Google Scholar
• Cheng L, Jones TD, McCarthy RP et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am. J. Pathol.166, 1533–1539 (2005).
   PubMed Web of Science ®Google Scholar
• Kratzke RA, Greatens TM, Rubins JB et al. Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res.56, 3415–3420 (1996).
   PubMed Web of Science ®Google Scholar
• Taga S, Osaki T, Ohgami A et al. Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma. Cancer80, 389–395 (1997).
   PubMed Web of Science ®Google Scholar
• Leonard C, Huret JL, Groupe francais de cytogenetique oncologique. From cytogenetics to cytogenomics of bladder cancers. Bull. Cancer89, 166–173 (2002).
   PubMed Web of Science ®Google Scholar
• Atkin NB, Baker MC, Wilson GD. Chromosome abnormalities and p53 expression in a small cell carcinoma of the bladder. Cancer Genet. Cytogenet.79, 111–114 (1995).
   Google Scholar
• Rohr UP, Rehfeld N, Pflugfelder L et al. Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer. Int. J. Cancer111, 259–263 (2004).
   Google Scholar
• Tamborini E, Bonadiman L, Negri T et al. Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer. Clin. Cancer Res.10, 8214–8219 (2004).
   PubMed Web of Science ®Google Scholar
• Pan CX, Yang XJ, Lopez-Beltran A et al. c-kit expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod. Pathol.18, 320–323 (2005).
   PubMed Web of Science ®Google Scholar
• Reck M, von Pawel J, Macha HN et al. Randomized Phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer. J. Natl Cancer Inst.95, 1118–1127 (2003).
   PubMedGoogle Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA100, 3983–3988 (2003).
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res.63, 5821–5828 (2003).
   PubMed Web of Science ®Google Scholar
• Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell121, 823–835 (2005).
   PubMed Web of Science ®Google Scholar
• Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res.65, 10946–10951 (2005).
   PubMed Web of Science ®Google Scholar
• Fukuoka M, Furuse K, Saijo N et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J. Natl Cancer Inst.83, 855–861 (1991).
   PubMed Web of Science ®Google Scholar
• Christopher ME, Seftel AD, Sorenson K, Resnick MI. Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. J. Urol.146, 382–388 (1991).
   PubMed Web of Science ®Google Scholar
• Grignon DJ, Ro JY, Ayala AG et al. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer69, 527–536 (1992).
   PubMed Web of Science ®Google Scholar
• Cheng L, Leibovich BC, Cheville JC et al. Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer88, 844–852 (2000).
   PubMed Web of Science ®Google Scholar
• Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG. Neurofibroma of the urinary bladder. Cancer86, 505–513 (1999).
   PubMed Web of Science ®Google Scholar
• Partanen S, Asikainen U. Oat cell carcinoma of the urinary bladder with ectopic adrenocorticotropic hormone production. Hum. Pathol.16, 313–315 (1985).
   PubMedGoogle Scholar
• Reyes CV, Soneru I. Small cell carcinoma of the urinary bladder with hypercalcemia. Cancer56, 2530–2533 (1985).
   PubMed Web of Science ®Google Scholar
• Ali SZ, Reuter VE, Zakowski MF. Small cell neuroendocrine carcinoma of the urinary bladder. A clinicopathologic study with emphasis on cytologic features. Cancer79, 356–361 (1997).
   PubMed Web of Science ®Google Scholar
• WHO Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein J (Eds). IARC Press, Lyon, France (2004).
   Google Scholar
• Mills SE, Wolfe JT 3rd, Weiss MA et al. Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocytochemical, and ultrastructural study of 12 cases. Am. J. Surg. Pathol.11, 606–617 (1987).
   PubMed Web of Science ®Google Scholar
• Soriano P, Navarro S, Gil M, Llombart-Bosch A. Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases. Virchows Arch.445, 292–297 (2004).
   PubMed Web of Science ®Google Scholar
• Jiang J, Ulbright TM, Younger C et al. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch. Pathol. Lab. Med.125, 921–923 (2001).
   PubMed Web of Science ®Google Scholar
• Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod. Pathol.8, 384–388 (1995).
   PubMed Web of Science ®Google Scholar
• Jones TD, Kernek KM, Yang XJ et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum. Pathol.36, 718–723 (2005).
   PubMed Web of Science ®Google Scholar
• Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J. Clin. Oncol.22, 3248–3254 (2004).
   PubMedGoogle Scholar
• Skarlos DV, Samantas E, Kosmidis P et al. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study. Ann. Oncol.5, 601–607 (1994).
   PubMed Web of Science ®Google Scholar
• Ciombor KK, Rocha Lima CM. Management of small cell lung cancer. Curr. Treat. Options Oncol.7, 59–68 (2006).
   PubMedGoogle Scholar
• Dreicer R, Manola J, Roth BJ, Cohen MB, Hatfield AK, Wilding G. Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study. J. Clin. Oncol.18, 1058–1061 (2000).
   PubMed Web of Science ®Google Scholar
• Bajorin DF, McCaffrey JA, Dodd PM et al. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a Phase II trial evaluating two dosing schedules. Cancer88, 1671–1678 (2000).
   PubMed Web of Science ®Google Scholar
• Reck M, von Pawel J, Macha HN et al. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years’-follow-up results from a randomised Phase III trial. Lung Cancer53, 67–75 (2006).
   PubMed Web of Science ®Google Scholar
• Loehrer PJ Sr, Ansari R, Gonin R et al. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study. J. Clin. Oncol.13, 2594–2599 (1995).
   PubMed Web of Science ®Google Scholar
• Lohrisch C, Murray N, Pickles T, Sullivan L. Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer86, 2346–2352 (1999).
   PubMed Web of Science ®Google Scholar
• Bex A, Nieuwenhuijzen JA, Kerst M et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology65, 295–299 (2005).
   PubMed Web of Science ®Google Scholar
• Pedersen AG, Kristjansen PE, Hansen HH. Prophylactic cranial irradiation and small cell lung cancer. Cancer Treat. Rev.15, 85–103 (1988).
   Google Scholar
• Auperin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N. Engl. J. Med.341, 476–484 (1999).
   PubMed Web of Science ®Google Scholar
• Isaka T, Maruno M, Sato M et al. Brain metastasis from small-cell neuroendocrine carcinoma of the urinary bladder: a case report. Brain Tumor Pathol.19, 117–122 (2002).
   Google Scholar
• Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J. Clin. Oncol.10, 890–895 (1992).
   PubMed Web of Science ®Google Scholar
• Choi NC, Carey RW. Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update. Int. J. Radiat. Oncol. Biol. Phys.17, 307–310 (1989).
   PubMed Web of Science ®Google Scholar
• Papac RJ, Son Y, Bien R, Tiedemann D, Keohane M, Yesner R. Improved local control of thoracic disease in small cell lung cancer with higher dose thoracic irradiation and cyclic chemotherapy. Int. J. Radiat. Oncol. Biol. Phys.13, 993–998 (1987).
   PubMed Web of Science ®Google Scholar
• Lester JF, Hudson E, Barber JB. Bladder preservation in small cell carcinoma of the urinary bladder: an institutional experience and review of the literature. Clin. Oncol.18, 608–611 (2006).
   PubMed Web of Science ®Google Scholar
• Gaspar LE, Gay EG, Crawford J, Putnam JB, Herbst RS, Bonner JA. Limited-stage small-cell lung cancer (stages I-III): observations from the National Cancer Data Base. Clin. Lung Cancer6, 355–360 (2005).
   PubMedGoogle Scholar